Kilitch Drugs (India) (BOM:524500) 3-Year Revenue Growth Rate : 29.90% (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) 3-Year Revenue Growth Rate?

Kilitch Drugs (India)'s Revenue per Share for the three months ended in Dec. 2024 was ₹34.96.

During the past 12 months, Kilitch Drugs (India)'s average Revenue per Share Growth Rate was 15.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 29.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 19.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Kilitch Drugs (India) was 51.80% per year. The lowest was -54.00% per year. And the median was 14.70% per year.

Competitive Comparison of Kilitch Drugs (India)'s 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kilitch Drugs (India)'s 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Kilitch Drugs (India) 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Kilitch Drugs (India) (BOM:524500) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Kilitch Drugs (India) 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kilitch Drugs (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

KILITCH:India

Address

Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088

Website

https://www.kilitch.com

Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines